DUBLIN--(BUSINESS WIRE)--The 'Neurologic Disorders Therapeutics - Global Strategic Business Report' report has been added to ResearchAndMarkets.com's offering.

都柏林--（商业新闻短讯）--“神经系统疾病治疗-全球战略商业报告”报告已添加到ResearchAndMarkets.com的产品中。

The global market for Neurologic Disorders Therapeutics was estimated at US$116.4 Billion in 2023, and is projected to reach US$149.7 Billion by 2030, growing at a CAGR of 3.7% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions..

2023年，全球神经系统疾病治疗市场估计为1164亿美元，预计到2030年将达到1497亿美元，2023年至2030年的复合年增长率为3.7%。这份综合报告对市场趋势、驱动因素和预测进行了深入分析，帮助您做出明智的商业决策。。

The growth in the neurologic disorders therapeutics market is driven by several factors. Firstly, the increasing prevalence of neurologic conditions, particularly among aging populations, has heightened the demand for effective treatments. Secondly, advancements in biotechnology and pharmaceutical research are continuously leading to the development of new and improved therapies, including gene therapies and neuroprotective agents.

神经系统疾病治疗市场的增长是由几个因素驱动的。首先，神经系统疾病的患病率越来越高，特别是在老年人群中，这增加了对有效治疗的需求。其次，生物技术和药物研究的进步不断导致新的和改进的疗法的发展，包括基因疗法和神经保护剂。

The expansion of healthcare infrastructure in emerging markets has also facilitated better access to neurologic care, contributing to market growth..

新兴市场医疗保健基础设施的扩展也促进了神经保健的更好获得，促进了市场的增长。。

Additionally, strategic collaborations between pharmaceutical companies, academic institutions, and research organizations are accelerating the discovery and commercialization of innovative treatments. The rise of digital health technologies, including telemedicine and wearable devices, is enhancing patient monitoring and management, leading to better outcomes.

此外，制药公司、学术机构和研究组织之间的战略合作正在加速创新疗法的发现和商业化。包括远程医疗和可穿戴设备在内的数字健康技术的兴起，正在加强患者的监测和管理，从而取得更好的结果。

Lastly, increased funding for neurologic research and the development of comprehensive treatment guidelines are fostering a more structured and effective approach to managing neurologic disorders..

最后，神经系统研究资金的增加和综合治疗指南的制定正在促进一种更结构化和有效的神经系统疾病管理方法。。

Key Insights:

关键见解：

Market Growth: Understand the significant growth trajectory of the Anticholinergic Drug Class segment, which is expected to reach US$45.2 Billion by 2030 with a CAGR of a 4.0%. The Analgesics Drug Class segment is also set to grow at 4.4% CAGR over the analysis period.

市场增长：了解抗胆碱能药物类细分市场的显着增长轨迹，预计到2030年将达到452亿美元，复合年增长率为4.0%。在分析期间，止痛药类药物的复合年增长率也将达到4.4%。

Regional Analysis: Gain insights into the U.S. market, estimated at $31.7 Billion in 2023, and China, forecasted to grow at an impressive 7.0% CAGR to reach $31.3 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

区域分析：深入了解美国市场，2023年估计为317亿美元，中国市场预计将以令人印象深刻的7.0%的复合年增长率增长，到2030年将达到313亿美元。。

Report Features:

报告功能：

Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.

综合市场数据：独立分析2023年至2030年的年销售额和市场预测（百万美元）。

In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.

深入的区域分析：深入了解主要市场，包括美国、中国、日本、加拿大、欧洲、亚太地区、拉丁美洲、中东和非洲。

Company Profiles: Coverage of major players such as AstraZeneca PLC, Biogen, Inc., Biohaven, Ltd., and more.

公司简介：涵盖阿斯利康公司、Biogen公司、Biohaven公司等主要公司。

Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

免费更新：免费获得一年的报告更新，随时了解最新的市场动态。

Key Questions Answered:

回答的关键问题：

How is the Global Neurologic Disorders Therapeutics Market expected to evolve by 2030?

预计到2030年，全球神经系统疾病治疗市场将如何发展？

What are the main drivers and restraints affecting the market?

影响市场的主要驱动因素和限制因素是什么？

Which market segments will grow the most over the forecast period?

在预测期内，哪些细分市场增长最大？

How will market shares for different regions and segments change by 2030?

到2030年，不同地区和细分市场的市场份额将如何变化？

Who are the leading players in the market, and what are their prospects?

谁是市场上的领先者，他们的前景如何？

Key Attributes:

关键属性：

Report Attribute

报表属性

Details

详细信息

No. of Pages

页数

289

289

Forecast Period

预测期

2023 - 2030

2023 - 2030

Estimated Market Value (USD) in 2023

2023年估计市值（美元）

$116.4 Billion

1164亿美元

Forecasted Market Value (USD) by 2030

2030年预测市场价值（美元）

$149.7 Billion

1497亿美元

Compound Annual Growth Rate

年均复合增长率

3.7%

3.7%

Regions Covered

覆盖的区域

Global

全球

Key Topics Covered:

涵盖的关键主题：

MARKET OVERVIEW

市场概况

Influencer Market Insights

影响者市场洞察

World Market Trajectories

世界市场轨迹

Global Economic Update

全球经济动态

Neurologic Disorders Therapeutics - Global Key Competitors Percentage Market Share in 2024 (E)

神经系统疾病治疗-2024年全球主要竞争对手市场份额百分比（E）

Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)

竞争性市场存在-2024年全球玩家的强大/活跃/利基/微不足道（E）

MARKET TRENDS & DRIVERS

市场趋势和驱动因素

Rising Prevalence of Neurologic Disorders Drives Demand for Therapeutics

神经系统疾病患病率的上升推动了对治疗药物的需求

Advancements in Neurotherapeutics Propel Market Growth

神经治疗药物的进步推动了市场的增长

Growing Awareness of Neurologic Health Expands Addressable Market Opportunity

对神经系统健康的认识不断提高，扩大了可寻址的市场机会

Development of Precision Medicine and Targeted Therapies Strengthens Business Case

精准医学和靶向治疗的发展加强了商业案例

Innovations in Neurostimulation and Neuromodulation Therapies Generate Market Interest

神经刺激和神经调节疗法的创新产生了市场兴趣

Development of Regenerative Medicine and Stem Cell Therapies Propels Market Growth

再生医学和干细胞疗法的发展推动了市场增长

FOCUS ON SELECT PLAYERS (Total 86 Featured)

专注于精选玩家（共86名精选）

AstraZeneca PLC

阿斯利康

Biogen, Inc.

股份有限公司Biogen。

Biohaven, Ltd.

生物港有限公司

Eisai Co., Ltd.

Eisai有限公司

H. Lundbeck A/S

H.灵北公司

Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals，股份有限公司。

Mitsubishi Tanabe Pharma Corporation

三菱田边制药公司

Neurelis, Inc.

股份有限公司Neurelis。

Neurocrine Biosciences, Inc.

Neurocrine Biosciences公司。

Neurona Therapeutics, Inc.

Neurona Therapeutics公司。

Ovid Therapeutics, Inc.

Ovid Therapeutics公司。

Pfizer, Inc.

。

Sanofi SA

赛诺菲公司

UCB SA

UCB SA

Voyager Therapeutics, Inc.

旅行者治疗公司。

For more information about this report visit https://www.researchandmarkets.com/r/eerbmd

有关此报告的更多信息，请访问https://www.researchandmarkets.com/r/eerbmd

About ResearchAndMarkets.com

关于ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com是全球领先的国际市场研究报告和市场数据来源。我们为您提供有关国际和地区市场、关键行业、顶尖公司、新产品和最新趋势的最新数据。